| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Case of Osimertinib-Induced Eosinophilic Pneumonia
|
Patel, Kanishka G.
|
|
|
23 |
7 |
p. 639-642
|
artikel
|
| 2 |
An Updated Review on Radiation Treatment Management in Thymus Cancers
|
Liu, Jason
|
|
|
23 |
7 |
p. 561-570
|
artikel
|
| 3 |
A Phase II Trial of Atezolizumab Plus Carboplatin Plus Pemetrexed Plus Bevacizumab in the Treatment of Patients with Stage IV Non-Squamous Non-Small Cell Lung Cancer: Big Ten Cancer Research Consortium (BTCRC)- LUN 17-139
|
Ardeshir-Larijani, Fatemeh
|
|
|
23 |
7 |
p. 578-584
|
artikel
|
| 4 |
A Phase 2 Study of Docetaxel, Ramucirumab, and Pembrolizumab for Patients With Metastatic or Recurrent Non–Small-Cell Lung Cancer (NSCLC) who Progressed on Platinum-Doublet and PD-1/PD-L1 Blockade
|
Osta, Badi El
|
|
|
23 |
7 |
p. e400-e404
|
artikel
|
| 5 |
A Review of Concurrent Chemo/Radiation, Immunotherapy, Radiation Planning, and Biomarkers for Locally Advanced Non-small Cell Lung Cancer and Their Role in the Development of ECOG-ACRIN EA5181
|
Varlotto, John Michael
|
|
|
23 |
7 |
p. 547-560
|
artikel
|
| 6 |
Biomarker-Driven Studies With Multi-targets and Multi-drugs by Next-Generation Sequencing for Patients With Non–Small-Cell Lung Cancer: An Open-Label, Multi-center, Phase II Adaptive Umbrella Trial and a Real-World Observational Study (CTONG1702&CTONG1705)
|
Liu, Si-Yang Maggie
|
|
|
23 |
7 |
p. e395-e399
|
artikel
|
| 7 |
Characteristics of High-Volume Lung Segmentectomy Hospitals: A Propensity Score-Matched Analysis
|
Mack, Shale J.
|
|
|
23 |
7 |
p. 600-607
|
artikel
|
| 8 |
Circulating Fatty Acid Profile as a Biomarker for Immunotherapy in Advanced Non-Small Cell Lung Cancer
|
Galli, Giulia
|
|
|
23 |
7 |
p. e489-e499
|
artikel
|
| 9 |
Comparative Clinical Outcomes Between EGFR Ex20ins and Wildtype NSCLC Treated with Immune Checkpoint Inhibitors
|
Girard, Nicolas
|
|
|
23 |
7 |
p. 571-577
|
artikel
|
| 10 |
Definitive Chemoradiation and Durvalumab Consolidation for Locally Advanced, Unresectable KRAS-mutated Non-Small Cell Lung Cancer
|
Guo, Matthew Z.
|
|
|
23 |
7 |
p. 620-629
|
artikel
|
| 11 |
Editorial Board
|
|
|
|
23 |
7 |
p. A11
|
artikel
|
| 12 |
Evaluating Real World Mutational Differences Between Hispanics and Asians in NSCLC at a Large Academic Institution in Los Angeles
|
Hsu, Robert
|
|
|
23 |
7 |
p. e443-e452
|
artikel
|
| 13 |
18F-FDG PET/CT for assessing heterogeneous metabolic response between primary tumor and metastases and prognosis in non-small cell lung cancer
|
Peng, Lirao
|
|
|
23 |
7 |
p. 608-619
|
artikel
|
| 14 |
Germline Testing of Patients With Non–small Cell Lung Cancers Demonstrating Incidentally Uncovered BRCA2 Apparent Pathogenic Germline Variants
|
Sorscher, Steven
|
|
|
23 |
7 |
p. e405-e407
|
artikel
|
| 15 |
Local Control With Single-Fraction Lung Stereotactic Body Radiotherapy is not influenced by Non-Small Cell Lung Cancer Histologic Subtype
|
Videtic, Gregory M.M.
|
|
|
23 |
7 |
p. e428-e434
|
artikel
|
| 16 |
Nab-Paclitaxel for Previously Treated Advanced Non–Small Cell Lung Cancer: Analysis of Safety and Efficacy for Patients With Renal Impairment
|
Yoneshima, Yasuto
|
|
|
23 |
7 |
p. 585-592
|
artikel
|
| 17 |
Neoadjuvant Prehabilitation Therapy for Locally Advanced Non–Small-Cell Lung Cancer: Optimizing Outcomes Throughout the Trajectory of Care
|
Schmid, Severin
|
|
|
23 |
7 |
p. 593-599
|
artikel
|
| 18 |
Oncogene Overlap Analysis of Circulating Cell-free Tumor DNA to Explore the Appropriate Criteria for Defining MET Copy Number–Driven Lung Cancer
|
Tsui, David C.C.
|
|
|
23 |
7 |
p. 630-638
|
artikel
|
| 19 |
Patterns of Failure and Optimal Treatment Paradigm for Large, Inoperable, Node-Negative Non–small Cell Lung Cancer
|
Schneider, Craig S.
|
|
|
23 |
7 |
p. e408-e414
|
artikel
|
| 20 |
Race is a Risk Factor for the Deferral of Resection and Radiation for Early-Stage Lung Cancer
|
Huang, Charles Y.
|
|
|
23 |
7 |
p. e460-e472
|
artikel
|
| 21 |
Safety and Efficacy of Dostarlimab in Patients With Recurrent/Advanced Non–small Cell Lung Cancer: Results from Cohort E of the Phase I GARNET Trial
|
Moreno, Victor
|
|
|
23 |
7 |
p. e415-e427
|
artikel
|
| 22 |
Study Design and Rationale for the PACE-LUNG Trial: A Multicenter, Single-Arm, Phase II Clinical Trial Evaluating the Efficacy of Additional Chemotherapy for Patients with EGFRm NSCLC with the Continued Presence of Plasma ctDNA EGFRm at Week 3 After Start of Osimertinib First-Line Treatment
|
Acker, Fabian
|
|
|
23 |
7 |
p. e473-e477
|
artikel
|
| 23 |
Table of Contents
|
|
|
|
23 |
7 |
p. A12-A16
|
artikel
|
| 24 |
Therapeutic Outcomes and Clinical Features of Advanced Non–Small Cell Lung Cancer Carrying KRAS Mutations: A Multicenter Real-life Retrospective Study
|
Mazzaschi, Giulia
|
|
|
23 |
7 |
p. e478-e488
|
artikel
|
| 25 |
Validation Study of New IASLC Histology Grading System in Stage I Non-Mucinous Adenocarcinoma Comparing With Minimally Invasive Adenocarcinoma
|
Woo, Wongi
|
|
|
23 |
7 |
p. e435-e442
|
artikel
|
| 26 |
Volume Doubling Time of Pulmonary Carcinoid Tumors Measured by Computed Tomography
|
Russ, Douglas H
|
|
|
23 |
7 |
p. e453-e459
|
artikel
|
Tijdschrift beschrijving